Virtu Financial LLC Nrx Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	BUY	$0.66 - $1.4 $30,498 - $64,693	46,210 New	46,210 $30,000
Q2 2022 Aug 09, 2022	BUY	$0.51 - $2.42 $6,527 - $30,973	12,799 New	12,799 $8,000
Q1 2022 May 17, 2022	SELL	$2.45 - $5.04 $150,878 - $310,378	-61,583 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$4.5 - $11.91 $277,123 - $733,453	61,583 New	61,583 $294,000

17.4K

Ticker NRXP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,641,296
Market Cap $185M
Description
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-10...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.